An	DT	a dt NUPOS
ex	FW	ex fw-la NUPOS
vivo	FW	vivo fw-la NUPOS
model	NN	model NN PennPOS
to	TO	to p-acp NUPOS
induce	VB	induce VBP PennPOS
early	JJ	early JJ PennPOS
fibrosis-like	JJ	fibrosis-like JJ PennPOS
changes	NNS	change NNS PennPOS
in	IN	in IN PennPOS
human	JJ	human JJ PennPOS
precision-cut	JJ	precision-cut JJ PennPOS
lung	NN	lung NN PennPOS
slices	NNS	slice NNS PennPOS
.	.	. . NUPOS

IPF	NN	IPF NN PennPOS
is	VBZ	be vbz NUPOS
a	DT	a dt NUPOS
devastating	JJ	devastating JJ PennPOS
chronic	JJ	chronic JJ PennPOS
interstitial	JJ	interstitial JJ PennPOS
lung	NN	lung NN PennPOS
disease	NN	disease NN PennPOS
(	(	( ( NUPOS
ILD	NN	ILD NN PennPOS
)	)	) ) NUPOS
characterized	VBN	characterize VBN PennPOS
by	IN	by IN PennPOS
lung	NN	lung NN PennPOS
tissue	NN	tissue NN PennPOS
scarring	NN	scarring NN PennPOS
and	CC	and cc NUPOS
high	JJ	high JJ PennPOS
morbidity	NN	morbidity NN PennPOS
.	.	. . NUPOS

Lung	NN	lung NN PennPOS
epithelial	JJ	epithelial JJ PennPOS
injury	NN	injury NN PennPOS
,	,	, , NUPOS
myofibroblast	NN	myofibroblast NN PennPOS
activation	NN	activation NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
deranged	JJ	deranged JJ PennPOS
repair	NN	repair NN PennPOS
are	VBP	be vbb NUPOS
believed	VBN	believe VBN PennPOS
to	TO	to p-acp NUPOS
be	VB	be vbi NUPOS
key	JJ	key JJ PennPOS
processes	NNS	process n2 NUPOS
involved	VBN	involve VBN PennPOS
in	IN	in IN PennPOS
disease	NN	disease NN PennPOS
onset	NN	onset NN PennPOS
and	CC	and cc NUPOS
progression	NN	progression NN PennPOS
but	CC	but cc-acp NUPOS
the	DT	the dt NUPOS
exact	JJ	exact JJ PennPOS
molecular	JJ	molecular JJ PennPOS
mechanisms	NNS	mechanism NNS PennPOS
behind	IN	behind IN PennPOS
IPF	NN	IPF NN PennPOS
remain	VBP	remain VBP PennPOS
unclear	JJ	unclear JJ PennPOS
.	.	. . NUPOS

Several	JJ	several JJ PennPOS
drugs	NNS	drug NNS PennPOS
have	VBP	have vhb NUPOS
been	VBN	be vbn NUPOS
shown	VBN	show VBN PennPOS
to	TO	to p-acp NUPOS
slow	VB	slow VBP PennPOS
disease	NN	disease NN PennPOS
progression	NN	progression NN PennPOS
,	,	, , NUPOS
but	CC	but cc-acp NUPOS
treatments	NNS	treatment NNS PennPOS
which	WDT	which r-crq NUPOS
halt	VBP	halt VBP PennPOS
or	CC	or cc NUPOS
reverse	VBP	reverse VBP PennPOS
IPF	NNP	IPF NN PennPOS
progression	NN	progression NN PennPOS
have	VBP	have vhb NUPOS
not	RB	not xx NUPOS
been	VBN	be vbn NUPOS
identified	VBN	identify VBN PennPOS
.	.	. . NUPOS

Ex	FW	ex fw-la NUPOS
vivo	FW	vivo fw-la NUPOS
models	NNS	model NNS PennPOS
of	IN	of pp-f NUPOS
human	JJ	human JJ PennPOS
lung	NN	lung NN PennPOS
have	VBP	have vhb NUPOS
been	VBN	be vbn NUPOS
proposed	VBN	propose VBN PennPOS
for	IN	for c-acp NUPOS
drug	NN	drug NN PennPOS
discovery	NN	discovery NN PennPOS
,	,	, , NUPOS
one	CD	one crd NUPOS
of	IN	of pp-f NUPOS
which	WDT	which r-crq NUPOS
is	VBZ	be vbz NUPOS
precision-cut	JJ	precision-cut JJ PennPOS
lung	NN	lung NN PennPOS
slices	NNS	slice NNS PennPOS
(	(	( ( NUPOS
PCLS	NNS	pcl NNS PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

Although	IN	although cs NUPOS
PCLS	NN	PCLS NN PennPOS
production	NN	production NN PennPOS
from	IN	from pp NUPOS
IPF	NN	IPF NN PennPOS
explants	NNS	explant NNS PennPOS
is	VBZ	be vbz NUPOS
possible	JJ	possible JJ PennPOS
,	,	, , NUPOS
IPF	NN	IPF NN PennPOS
explants	NNS	explant NNS PennPOS
are	VBP	be vbb NUPOS
rare	JJ	rare JJ PennPOS
and	CC	and cc NUPOS
typically	RB	typical RB PennPOS
represent	VBP	represent VBP PennPOS
end-stage	JJ	end-stage JJ PennPOS
disease	NN	disease NN PennPOS
.	.	. . NUPOS

Here	RB	here av NUPOS
we	PRP	we pns12 NUPOS
present	VBP	present VBP PennPOS
a	DT	a dt NUPOS
novel	JJ	novel JJ PennPOS
model	NN	model NN PennPOS
of	IN	of pp-f NUPOS
early	JJ	early JJ PennPOS
fibrosis-like	JJ	fibrosis-like JJ PennPOS
changes	NNS	change NNS PennPOS
in	IN	in IN PennPOS
human	JJ	human JJ PennPOS
PCLS	NN	PCLS NN PennPOS
derived	VBN	derive VBN PennPOS
from	IN	from pp NUPOS
patients	NNS	patient NNS PennPOS
without	IN	without IN PennPOS
ILD/IPF	NN	ILD/IPF NN PennPOS
using	VBG	use VBG PennPOS
a	DT	a dt NUPOS
combination	NN	combination NN PennPOS
of	IN	of pp-f NUPOS
profibrotic	JJ	profibrotic JJ PennPOS
growth	NN	growth NN PennPOS
factors	NNS	factor NNS PennPOS
and	CC	and cc NUPOS
signaling	VBG	signal VBG PennPOS
molecules	NNS	molecule NNS PennPOS
.	.	. . NUPOS

Fibrotic-like	JJ	fibrotic-like JJ PennPOS
changes	NNS	change NNS PennPOS
of	IN	of pp-f NUPOS
PCLS	NNS	pcl NNS PennPOS
were	VBD	be vbd NUPOS
qualitatively	RB	qualitative RB PennPOS
analyzed	VBN	analyse VBN PennPOS
by	IN	by IN PennPOS
histology	NN	histology NN PennPOS
and	CC	and cc NUPOS
immunofluorescence	NN	immunofluorescence NN PennPOS
and	CC	and cc NUPOS
quantitatively	RB	quantitative RB PennPOS
by	IN	by IN PennPOS
WST1	NN	WST1 NN PennPOS
,	,	, , NUPOS
RT-qPCR	NN	RT-qPCR NN PennPOS
,	,	, , NUPOS
WB	NNP	wb NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
ELISA	NN	elisa NN PennPOS
.	.	. . NUPOS

PCLS	NN	PCLS NN PennPOS
remained	VBD	remain VBD PennPOS
viable	JJ	viable JJ PennPOS
after	IN	after c-acp NUPOS
5	CD	5 crd NUPOS
days	NNS	day n2 NUPOS
of	IN	of pp-f NUPOS
treatment	NN	treatment NN PennPOS
and	CC	and cc NUPOS
fibrotic	JJ	fibrotic JJ PennPOS
gene	NN	gene NN PennPOS
expression	NN	expression NN PennPOS
(	(	( ( NUPOS
FN1	NN	FN1 NN PennPOS
,	,	, , NUPOS
SERPINE1	NN	SERPINE1 NN PennPOS
,	,	, , NUPOS
COL1A1	NN	COL1A1 NN PennPOS
,	,	, , NUPOS
CTGF	NN	Ctgf NN PennPOS
,	,	, , NUPOS
MMP7	NN	MMP7 NN PennPOS
and	CC	and cc NUPOS
ACTA2	NN	ACTA2 NN PennPOS
)	)	) ) NUPOS
increased	VBD	increase VBD PennPOS
as	RB	as a-acp NUPOS
early	JJ	early JJ PennPOS
as	IN	as c-acp NUPOS
24h	NN	24h NN PennPOS
of	IN	of pp-f NUPOS
treatment	NN	treatment NN PennPOS
,	,	, , NUPOS
with	IN	with pp NUPOS
increases	NNS	increase NNS PennPOS
in	IN	in IN PennPOS
protein	NN	protein NN PennPOS
levels	NNS	level NNS PennPOS
at	IN	at pp NUPOS
48	CD	48 CD PennPOS
hours	NNS	hour NNS PennPOS
and	CC	and cc NUPOS
increased	VBD	increase VBD PennPOS
deposition	NN	deposition NN PennPOS
of	IN	of pp-f NUPOS
extracellular	JJ	extracellular JJ PennPOS
matrix	NN	matrix NN PennPOS
.	.	. . NUPOS

Alveolar	JJ	alveolar JJ PennPOS
epithelium	NN	epithelium NN PennPOS
reprogramming	NN	reprogramming NN PennPOS
was	VBD	be vbd NUPOS
evident	JJ	evident JJ PennPOS
by	IN	by IN PennPOS
decreases	NNS	decrease NNS PennPOS
in	IN	in IN PennPOS
SFTPC	NNP	SFTPC NN PennPOS
and	CC	and cc NUPOS
loss	NN	loss NN PennPOS
of	IN	of pp-f NUPOS
HOPX	NNP	HOPX NNP PennPOS
In	IN	in IN PennPOS
summary	NN	summary NN PennPOS
,	,	, , NUPOS
using	VBG	use VBG PennPOS
human-derived	JJ	human-derived JJ PennPOS
PCLS	NNS	pcl NNS PennPOS
from	IN	from pp NUPOS
patients	NNS	patient NNS PennPOS
without	IN	without IN PennPOS
ILD/IPF	NN	ILD/IPF NN PennPOS
,	,	, , NUPOS
we	PRP	we pns12 NUPOS
established	VBD	establish VBD PennPOS
a	DT	a dt NUPOS
novel	JJ	novel JJ PennPOS
ex	FW	ex fw-la NUPOS
vivo	FW	vivo fw-la NUPOS
model	NN	model NN PennPOS
which	WDT	which r-crq NUPOS
displays	VBZ	display VBZ PennPOS
characteristics	NNS	characteristic NNS PennPOS
of	IN	of pp-f NUPOS
early	JJ	early JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
and	CC	and cc NUPOS
could	MD	can vmd NUPOS
be	VB	be vbi NUPOS
used	VBN	use VBN PennPOS
to	TO	to p-acp NUPOS
evaluate	VB	evaluate VBP PennPOS
novel	JJ	novel JJ PennPOS
therapies	NNS	therapy NNS PennPOS
and	CC	and cc NUPOS
study	NN	study NN PennPOS
early-stage	JJ	early-stage JJ PennPOS
IPF	NN	IPF NN PennPOS
pathomechanisms	NNS	pathomechanism NNS PennPOS
.	.	. . NUPOS

